Outcomes of Lymph Node Dissection for Nonmetastatic Pancreatic Neuroendocrine Tumors: To Dissect or Not To Dissect

  • Jie Hua
  • Si Shi
  • Xianjun YuEmail author
Pancreatic Tumors



The authors declare no conflict of interest.


  1. 1.
    Mao R, Zhao H, Li K, et al. Outcomes of lymph node dissection for non-metastatic pancreatic neuroendocrine tumors: a propensity score-weighted analysis of the National Cancer Database. Ann Surg Oncol. 2019;26:2722–9.CrossRefGoogle Scholar
  2. 2.
    Kazanjian KK, Reber HA, Hines OJ, et al. Resection of pancreatic neuroendocrine tumors: results of 70 cases. Arch Surg. 2006;141:765–70.CrossRefGoogle Scholar
  3. 3.
    Krampitz GW, Norton JA, Poultsides GA, et al. Lymph nodes and survival in pancreatic neuroendocrine tumors. Arch Surg. 2012;147:820–7.CrossRefGoogle Scholar
  4. 4.
    Jutric Z, Grendar J, Hoen HM, et al. Regional metastatic behavior of nonfunctional pancreatic neuroendocrine tumors: impact of lymph node positivity on survival. Pancreas. 2017;46:898–903.CrossRefGoogle Scholar
  5. 5.
    Hashim YM, Trinkaus KM, Linehan DC, et al. Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs). Ann Surg. 2014;259:197–203.CrossRefGoogle Scholar
  6. 6.
    Zhang XF, Xue F, Dong DH, et al. New nodal staging for primary pancreatic neuroendocrine tumors: a multi-institutional and National Data Analysis. Ann Surg. 2019. Scholar
  7. 7.
    Bosman FT, Carneiro F, Hruban RH, Theise ND. World Health Organization classification of tumours of the digestive system. 4th ed. Lyon: IARC; 2010.Google Scholar

Copyright information

© Society of Surgical Oncology 2019

Authors and Affiliations

  1. 1.Department of Pancreatic SurgeryFudan University Shanghai Cancer CenterShanghaiChina

Personalised recommendations